证券记录 · 已归档季度
SOLV
Solventum Corporation · Healthcare · Medical - Instruments & Supplies
17被追踪持有人
-2Δ持有人
26.13M持有股份
$1.73B报告持仓市值
+2新建仓位
−4清仓
动量输入（同类管理人）：
持有人广度 -10.5% ·
股份流向 -0.2% ·
净新建仓位 -11.8%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 555.50K | $48.88M | n/a | −1 |
| Q2 2026 | 149 | +2 | 80.14M | $6.18B | +13 | −12 |
| Q1 2026 | 151 | -8 | 79.93M | $5.22B | +3 | −12 |
| Q4 2025 | 158 | +1 | 87.71M | $6.95B | +3 | −1 |
| Q3 2025 | 22 | +1 | 55.78M | $4.07B | +1 | −1 |
| Q2 2025 | 19 | 0 | 51.64M | $3.92B | +2 | −2 |
| Q1 2025 | 16 | -1 | 25.10M | $1.91B | +1 | −2 |
| Q4 2024 | 17 | -2 | 26.13M | $1.73B | +2 | −4 |
| Q3 2024 | 18 | +2 | 20.00M | $1.39B | +4 | −2 |
| Q2 2024 | 16 | n/a | 16.58M | $874.59M | n/a | n/a |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Trian Fund Management ✦ | 8.46M | +18.8% | $559.05M | 14.4% | ▲ Add | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (被动) | 6.19M | n/a | $409.09M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 3.46M | +3.4% | $227.99M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (被动) | 3.08M | +0.1% | $203.74M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Baupost Group ✦ | 1.45M | -20.5% | $95.54M | 2.8% | ▼ Trim | 3 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 1.43M | -3.5% | $94.26M | 0.1% | ▼ Trim | 3 | SEC ↗ ×4 |
| 7 | Arrowstreet Capital ✦ | 1.19M | +41.1% | $78.83M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 212.15K | -62.0% | $14.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 200.54K | +0.4% | $13.25M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 10 | Gotham Asset Management ✦ | 190.75K | +2.0% | $12.60M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 117.98K | +175.6% | $7.79M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 12 | Adage Capital Partners ✦ | 107.62K | -22.4% | $7.11M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Bridgewater Associates ✦ | 9.28K | -50.8% | $613,169 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | GAMCO Investors ✦ | 8.92K | +29.4% | $589,519 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 8.50K | +22.7% | $561,774 | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 16 | Marshall Wace ✦ | 5.72K | 新增 | $377,995 | 0.0% | New | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 987 | 新增 | $65,201 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $377,995 | 0.0% |
| Citadel Advisors | $65,201 | 0.0% |
已清仓
| Point72 Asset Management | $50.95M | 曾为 0.2% |
| Capital World Investors | $27.28M | 曾为 0.0% |
| Renaissance Technologies | $1.18M | 曾为 0.0% |
| Markel Group | $52,290 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 873 持有人, 128.07M 股份, $8.18B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据